A molecular imaging technique called Positron Emission Tomography (PET) is being developed to enable real-time monitoring of the biology of the patient at a molecular level, which would help bring greater insight into cancer treatments.

Dr Kramer-Marek is exploring the use of molecular imaging as a non-invasive means to target specific biomarkers that can be used to gauge the effectiveness of treatment. The ability to monitor these markers in real-time would allow treatment to be tailored for each patient and could also speed up drug discovery.

See more at: http://www.icr.ac.uk/news-features/latest-features/using-molecular-imaging-to-take-a-snapshot-of-cancer-and-its-treatment